SWE-NEO: Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial.

Helgadottir H, Carneiro A, Portelli F, Papadakis K, Björkström K, Yang M, Johansson I, Skogvall Svensson I, Jazrawi A, Hallgren A, Harbst K, Bark R, Egyhazi Brage S, Berglund A, Isaksson K, Wickström S, Nilsson J, Ny L, Jönsson G, Olofsson Bagge R